BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meyer NJ, Reilly JP, Anderson BJ, Palakshappa JA, Jones TK, Dunn TG, Shashaty MGS, Feng R, Christie JD, Opal SM. Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration. Crit Care Med 2018;46:21-8. [PMID: 28991823 DOI: 10.1097/CCM.0000000000002749] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Wilson JG, Calfee CS. ARDS Subphenotypes: Understanding a Heterogeneous Syndrome. Crit Care 2020;24:102. [PMID: 32204722 DOI: 10.1186/s13054-020-2778-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
2 Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol 2020;16:20-31. [PMID: 31511662 DOI: 10.1038/s41581-019-0199-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
3 Sinha P, Calfee CS. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine. Curr Opin Crit Care 2019;25:12-20. [PMID: 30531367 DOI: 10.1097/MCC.0000000000000571] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 29.5] [Reference Citation Analysis]
4 Zhang YY, Ning BT. Signaling pathways and intervention therapies in sepsis. Signal Transduct Target Ther 2021;6:407. [PMID: 34824200 DOI: 10.1038/s41392-021-00816-9] [Reference Citation Analysis]
5 Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, Zhao HY, Chen DK, Ma WT. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases. Int J Mol Sci 2021;22:13009. [PMID: 34884813 DOI: 10.3390/ijms222313009] [Reference Citation Analysis]
6 Richendrfer HA, Levy MM, Elsaid KA, Schmidt TA, Zhang L, Cabezas R, Jay GD. Recombinant Human Proteoglycan-4 Mediates Interleukin-6 Response in Both Human and Mouse Endothelial Cells Induced Into a Sepsis Phenotype. Crit Care Explor 2020;2:e0126. [PMID: 32695993 DOI: 10.1097/CCE.0000000000000126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Denstaedt SJ, Singer BH, Standiford TJ. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation. Front Immunol 2018;9:2446. [PMID: 30459764 DOI: 10.3389/fimmu.2018.02446] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
8 Wick KD, McAuley DF, Levitt JE, Beitler JR, Annane D, Riviello ED, Calfee CS, Matthay MA. Promises and challenges of personalized medicine to guide ARDS therapy. Crit Care 2021;25:404. [PMID: 34814925 DOI: 10.1186/s13054-021-03822-z] [Reference Citation Analysis]
9 Anderson MR, Udupa JK, Edwin E, Diamond JM, Singer JP, Kukreja J, Hays SR, Greenland JR, Ferrante A, Lippel M, Blue T, McBurnie A, Oyster M, Kalman L, Rushefski M, Wu C, Pednekar G, Liu W, Arcasoy S, Sonett J, D'Ovidio F, Bacchetta M, Newell JD, Torigian D, Cantu E, Farber DL, Giles JT, Tong Y, Palmer S, Ware LB, Hancock WW, Christie JD, Lederer DJ. Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study. J Heart Lung Transplant 2019;38:1246-56. [PMID: 31474492 DOI: 10.1016/j.healun.2019.08.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
10 Giannini HM, Meyer NJ. Genetics of Acute Respiratory Distress Syndrome: Pathways to Precision. Crit Care Clin 2021;37:817-34. [PMID: 34548135 DOI: 10.1016/j.ccc.2021.05.006] [Reference Citation Analysis]
11 Palma P, Rello J. Precision medicine for the treatment of sepsis: recent advances and future prospects. Expert Review of Precision Medicine and Drug Development 2019;4:205-13. [DOI: 10.1080/23808993.2019.1626714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Zhao X, Qi H, Zhou J, Xu S, Gao Y. Treatment with Recombinant Interleukin-15 (IL-15) Increases the Number of T Cells and Natural Killer (NK) Cells and Levels of Interferon-γ (IFN-γ) in a Rat Model of Sepsis. Med Sci Monit 2019;25:4450-6. [PMID: 31201735 DOI: 10.12659/MSM.914026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Stancioiu F, Papadakis GZ, Kteniadakis S, Izotov BN, Coleman MD, Spandidos DA, Tsatsakis A. A dissection of SARS‑CoV2 with clinical implications (Review). Int J Mol Med 2020;46:489-508. [PMID: 32626922 DOI: 10.3892/ijmm.2020.4636] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
14 Nunnally ME, Ferrer R, Martin GS, Martin-Loeches I, Machado FR, De Backer D, Coopersmith CM, Deutschman CS; Surviving Sepsis Campaign Reasearch Committee. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp 2021;9:34. [PMID: 34212256 DOI: 10.1186/s40635-021-00400-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Xiong S, Hong Z, Huang LS, Tsukasaki Y, Nepal S, Di A, Zhong M, Wu W, Ye Z, Gao X, Rao GN, Mehta D, Rehman J, Malik AB. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest 2020;130:3684-98. [PMID: 32298238 DOI: 10.1172/JCI136908] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
16 Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, Beitler JR, Wick KD, Curley MAQ, Constantin JM, Levitt JE, Calfee CS. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med 2020;46:2136-52. [PMID: 33206201 DOI: 10.1007/s00134-020-06296-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
17 Xiong CQ, Zhou HC, Wu J, Guo NZ. The Protective Effects and the Involved Mechanisms of Tanshinone IIA on Sepsis-Induced Brain Damage in Mice. Inflammation 2019;42:354-64. [PMID: 30255286 DOI: 10.1007/s10753-018-0899-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Liu L, Sun B. Neutrophil pyroptosis: new perspectives on sepsis. Cell Mol Life Sci 2019;76:2031-42. [PMID: 30877336 DOI: 10.1007/s00018-019-03060-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
19 Dahmer MK, Quasney MW, Sapru A, Gildengorin G, Curley MAQ, Matthay MA, Flori H; BALI and RESTORE Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure. Pediatr Crit Care Med 2018;19:930-8. [PMID: 30095747 DOI: 10.1097/PCC.0000000000001680] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kangelaris KN, Shashaty MGS, Lazaar AL, Bayliffe AI, Gallop RJ, Miano TA, Dunn TG, Johansson E, Abbott J, Jauregui A, Deiss T, Vessel K, Belzer A, Zhuo H, Matthay MA, Meyer NJ, Christie JD. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care 2019;23:400. [PMID: 31818332 DOI: 10.1186/s13054-019-2684-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Leong K, Gaglani B, Khanna AK, McCurdy MT. Novel Diagnostics and Therapeutics in Sepsis. Biomedicines 2021;9:311. [PMID: 33803628 DOI: 10.3390/biomedicines9030311] [Reference Citation Analysis]
22 Reilly JP, Calfee CS, Christie JD. Acute Respiratory Distress Syndrome Phenotypes. Semin Respir Crit Care Med 2019;40:19-30. [PMID: 31060085 DOI: 10.1055/s-0039-1684049] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
23 Ge Y, Chen J, Hu Y, Chen X, Huang M. IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome. Mediators Inflamm 2021;2021:6370911. [PMID: 34955683 DOI: 10.1155/2021/6370911] [Reference Citation Analysis]
24 Clark KEN, Collas O, Lachmann H, Singh A, Buckley J, Bhagani S. Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series. Rheumatol Adv Pract 2020;4:rkaa040. [PMID: 32964179 DOI: 10.1093/rap/rkaa040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
25 Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J. The Potential of Phage Therapy in Sepsis. Front Immunol 2017;8:1783. [PMID: 29312312 DOI: 10.3389/fimmu.2017.01783] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
26 Sinha P, Calfee CS. Inflammasomes Assemble: Cytoplasmic Guardians or Fallen Heroes? Crit Care Med 2019;47:1161-3. [PMID: 31305304 DOI: 10.1097/CCM.0000000000003872] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]